Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Chronic Insomnia
NCT04635098Completed
- Sponsor
- Ruijin Hospital
- Start
- May 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Insomnia comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Sleep efficiency. Started May 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04635098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635098.